Last update :
06/12/2021
Anticancer drug   Gemtuzumab ozogamicin  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Mylotarg Belgium, Colombia, France, Germany, Great Britain, Spain, United States of America, Venezuela
References   Injection   References : Gemtuzumab ozogamicin  
Type Publication
1913 Manufacturer Gemtuzumab ozogamicin (Mylotarg® - Summary of Product Characteristics)
Pfizer Europe 2020

  Mentions Légales